ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2526

Development of the Hospital Emergency Advocacy & Treatment Kit (HEAT Kit) for Patients with Vasculitis

Sarah Jones1, Pamela Squires2 and Donna McArthur3, 1Eosinophilic & Rare Disease Cooperative, Tucson, AZ, 2Eosinophilic & Rare Disease Cooperative, Tucson, 3Adjunct professor of nursing, Vanderbilt School of Nursing; Adjunct clinical professor, University of Arizona College of Nursing & Dept. of Neurology, Tucson, AZ

Meeting: ACR Convergence 2024

Keywords: Access to care, ANCA associated vasculitis, education, patient, quality of care, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: All forms of vasculitis are rare with patients frequently experiencing poor or extended care in the hospital and ED settings. The ERDC founder experienced this first hand when being evaluated for what was eventually  diagnosed as EGPA. The experience led them to develop a durable and convenient hospital and emergency kit that met reported experiential pain points and enables people with vasculitis to educate providers and improve quality of care at hospital and other health care appointments. The purpose of this study was to explore a broader sample of the vasculitis community’s experiences in health care settings to further inform the HEAT Kit development and dissemination. 

Methods: Ethnographic interviews for individuals who wanted to supplement their survey data. Survey administered to patients and care partners of people with vasculitis. Questions included: basic demographic and disease state information; pain points when presenting at a hospital; types of pain points; frequency of pain points with vasculitis specialist; other disease specialists and PCPs; frequency of hospitalizations, and percent of time alone when in the hospital or ED.

Results: An anonymous 15 question survey was sent to 256 people with vasculitis. 106 patients completed  the survey – 31% GPA, 24% MPA, 24%  EGPA, 21% other vasculitis. (Top pain points related to wishing the patient had remembered to tell the provider about a symptom or part of history, a lack of understanding about vasculitis and symptoms being discounted. Patients reported they experience these pain points 61% of the time in the ED, 50% with other specialists, 42% of the time with PCPs and 31% of the time with their vasculitis specialist. 73% of respondents have between three to six providers they see frequently, 20% have seven or more they see regularly. Forty-seven percent have been hospitalized between 1-4 times in the last 12 months. Thirty-seven percent of the respondents report they were alone in the hospital or ED at least 50% of the time, and 16% were always alone.

Conclusion: Survey results supported the need for further development of disease-specific HEAT kits  based on the  hospital and ED experiences of patients with vasculitis. Subsequently, ERDC created and tested a HEAT Kit over the course of 2 years. These kits have been distributed to more than 500 people impacted by vasculitis in 43 states and 13 countries. Feedback from patients indicates improved confidence and increased ease of communicating with providers in high stress settings. Patients also report use of kit for non-emergent appointments with specialists and PCPs.

Supporting image 1

Same components of Hospital Emergency Advocacy & Treatment Kit

Supporting image 2

Feedback received after vasculitis patients received HEAT Kits, including feedback from a vasculitis expert physician


Disclosures: S. Jones: None; P. Squires: None; D. McArthur: None.

To cite this abstract in AMA style:

Jones S, Squires P, McArthur D. Development of the Hospital Emergency Advocacy & Treatment Kit (HEAT Kit) for Patients with Vasculitis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/development-of-the-hospital-emergency-advocacy-treatment-kit-heat-kit-for-patients-with-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-the-hospital-emergency-advocacy-treatment-kit-heat-kit-for-patients-with-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology